Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

Jones, who has led connectivity solutions for J&J’s surgical robots, announced his departure on LinkedIn.

However, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation ...

The document clarifies that EtO falls within the scope of the Medical Device Regulation and the In Vitro Diagnostic ...

Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of ...

Innoventric, a leader in transcatheter tricuspid regurgitation (TR) treatment, today announced a $28.5 million Series B funding round to advance its revolutionary cross-caval technology, bringing the ...

Orthopedics competitors Stryker and Zimmer Biomet outlined two different approaches to growth in their latest earnings updates. Stryker CEO Kevin Lobo highlighted the company’s recent acquisitions on ...

Study author Philippe Genereux said the trial data “shatter 60 years of ingrained belief on the treatment for severe aortic ...

Artificial intelligence tools could help solve workforce challenges. Implementation, however, can be difficult, pushing ...